Adjuvant activities of saponins from traditional Chinese medicinal herbs

Vaccine

Volumn 27, Issue 36, 2009, Pages 4883-4890

  Song, Xiaoming ^a   Hu, Songhua ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

Adjuvant; Medicinal herb; Saponin; Traditional Chinese medicine (TCM)

Indexed keywords

ANTIGEN; ASTRAGALOSIDE I; ASTRAGALOSIDE II; ASTRAGALOSIDE IV; ASTRAGALOSIDE VII; BRACHYOISIDE A; BRACHYOISIDE B; BRACHYOISIDE C; CYCLOCEPHALOSIDE I; CYCLOCEPHALOSIDE II; CYTOKINE; DNA VACCINE; GINSENOSIDE; GINSENOSIDE RB 1; GINSENOSIDE RD; GINSENOSIDE RE; GINSENOSIDE RG 1; GINSENOSIDE RG 2; GINSENOSIDE RG 3; GINSENOSIDE RH 1; GINSENOSIDE RH 4; GLYCYRRHIZIC ACID; IMMUNOLOGICAL ADJUVANT; NOTOGINSENOSIDE; NOTOGINSENOSIDE R1; NOTOGINSENOSIDE R2; RECOMBINANT VACCINE; SAPONIN DERIVATIVE; TRITERPENE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACHYRANTHES; ACHYRANTHES BIDENTATA; ASTRAGALUS PLANT; CHINESE HERB; COCHINCHINA MOMORDICA; DRUG ACTIVITY; DRUG STRUCTURE; GINSENG; GLYCYRRHIZA URALENSIS; INNATE IMMUNITY; PANAX NOTOGINSENG; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION;

ADJUVANTS, IMMUNOLOGIC; CHINA; HUMANS; PLANTS, MEDICINAL; SAPONINS; VACCINES;

EID: 67650470867     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.06.033     Document Type: Review

References (82)

1. Singh M., and O'Hagan D.T. Recent advances in veterinary vaccine adjuvants. Int J Parasitol 33 May (5-6) (2003) 469-478
2. O'Hagan D.T., MacKichan M.L., and Singh M. Recent developments in adjuvants for vaccines against infectious diseases. Biomol Eng 18 October (3) (2001) 69-85
3. Medzhitov R., and Janeway Jr. C.A. Innate immunity: the virtues of a nonclonal system of recognition. Cell 91 October (3) (1997) 295-298
4. Milgate J., and Roberts D.C.K. The nutritional and biological significance of saponins. Nutr Res 15 8 (1995) 1223-1248
5. Campbell J.B. Saponins. In: Stewart-Tull D.E.S. (Ed). The theory and practical application of adjuvants (1995), John Wiley & Sons Ltd., New York 95-127
6. Pillion D.J., Amsden J.A., Kensil C.R., and Recchia J. Structure-function relationship among Quillaja saponins serving as excipients for nasal and ocular delivery of insulin. J Pharm Sci 85 May (5) (1996) 518-524
7. Marciani D.J. Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity. Drug Discov Today 8 October (20) (2003) 934-943
8. Rhodes J. Covalent chemical events in immune induction: fundamental and therapeutic aspects. Immunol Today 17 September (9) (1996) 436-441
9. Takahashi H., Takeshita T., Morein B., Putney S., Germain R.N., and Berzofsky J.A. Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature 344 April (6269) (1990) 873-875
10. Soltysik S., Wu J.Y., Recchia J., Wheeler D.A., Newman M.J., Coughlin R.T., et al. Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function. Vaccine 13 15 (1995) 1403-1410
11. Kensil C.R., Patel U., Lennick M., and Marciani D. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. J Immunol 146 2 (1991) 431-437
12. Palatnik de Sousa C.B., Santos W.R., Casas C.P., Paraguai de Souza E., Tinoco L.W., da Silva B.P., et al. Protective vaccination against murine visceral leishmaniasis using aldehyde-containing Quillaja saponaria sapogenins. Vaccine 22 19 (2004) 2470-2479
13. Nico D., Santos F.N., Borja-Cabrera G.P., Palatnik M., and Palatnik de Sousa C.B. Assessment of the monoterpene, glycidic and triterpene-moieties' contributions to the adjuvant function of the CP05 saponin of Calliandra pulcherrima Benth during vaccination against experimental visceral leishmaniasis. Vaccine 25 January (4) (2007) 649-658
14. Silva B.P., Soares J.B., Souza E.P., Palatnik M., Sousa C.B., and Parente J.P. Pulcherrimasaponin, from the leaves of Calliandra pulcherrima, as adjuvant for immunization in the murine model of visceral leishmaniasis. Vaccine 23 January (8) (2005) 1061-1071
15. Waite D.C., Jacobson E.W., Ennis F.A., Edelman R., White B., Kammer R., et al. Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant QS-21. Vaccine 19 July (8-29) (2001) 3957-3967
16. Schetters T.P., Kleuskens J., Scholtes N., and Bos H.J. Vaccination of dogs against Babesia canis infection using parasite antigens from in vitro culture. Parasite Immunol 14 May (3) (1992) 295-305
17. Schetters T.P., Strydom T., Crafford D., Kleuskens J.A., van de Crommert J., and Vermeulen A.N. Immunity against Babesia rossi infection in dogs vaccinated with antigens from culture supernatants. Vet Parasitol 144 March (1-2) (2007) 10-19
18. Marciani D.J., Pathak A.K., Reynolds R.C., Seitz L., and May R.D. Altered immunomodulating and toxicological properties of degraded Quillaja saponaria Molina saponins. Int Immunopharmacol 1 April (4) (2001) 813-818
19. Parra L.E., Borja-Cabrera G.P., Santos F.N., Souza L.O., Palatnik-de-Sousa C.B., and Menz I. Safety trial using the Leishmune vaccine against canine visceral leishmaniasis in Brazil. Vaccine 25 March (12) (2007) 2180-2186
20. Sun J., Hu S., and Song X. Adjuvant effects of protopanaxadiol and protopanaxatriol saponins from ginseng roots on the immune responses to ovalbumin in mice. Vaccine 25 January (6) (2007) 1114-1120
21. Jie Y.H., Cammisuli S., and Baggiolini M. Immunomodulatory effects of Panax ginseng C.A. Meyer in the mouse. Agents Actions 15 October (3-4) (1984) 386-391
22. Kenarova B., Neychev H., Hadjiivanova C., and Petkov V.D. Immunomodulating activity of ginsenoside Rg1 from Panax ginseng. Jpn J Pharmacol 54 December (4) (1990) 447-454
23. Rivera E., Daggfeldt A., and Hu S. Ginseng extract in aluminium hydroxide adjuvanted vaccines improves the antibody response of pigs to porcine parvovirus and Erysipelothrix rhusiopathiae. Vet Immunol Immunopathol 91 January (10) (2003) 19-27
24. Kong X., Hu Y., Rui R., Wang D., and Li X. Effects of Chinese herbal medicinal ingredients on peripheral lymphocyte proliferation and serum antibody titer after vaccination in chicken. Int Immunopharmacol 4 July (7) (2004) 975-982
25. Rivera E., Hu S., and Concha C. Ginseng and aluminium hydroxide act synergistically as vaccine adjuvants. Vaccine 21 March (11-12) (2003) 1149-1157
26. Sun J., Song X., Hu S., and Ginsenoside. Rg1 and aluminum hydroxide synergistically promote immune responses to ovalbumin in BALB/c mice. Clin Vaccine Immunol 15 February (2) (2008) 303-307
27. Hu S., Concha C., Lin F., and Persson Waller K. Adjuvant effect of ginseng extracts on the immune responses to immunisation against Staphylococcus aureus in dairy cattle. Vet Immunol Immunopathol 91 January (1) (2003) 29-37
28. Song X., Bao S., Wu L., and Hu S. Ginseng stem-leaf saponins (GSLS) and mineral oil act synergistically to enhance the immune responses to vaccination against foot-and-mouth disease in mice. Vaccine 27 January (1) (2009) 51-55
29. Rivera E., Ekholm Pettersson F., Inganas M., Paulie S., and Gronvik K.O. The Rb1 fraction of ginseng elicits a balanced Th1 and Th2 immune response. Vaccine 23 November (46-47) (2005) 5411-5419
30. Yesilada E., Bedir E., Calis I., Takaishi Y., and Ohmoto Y. Effects of triterpene saponins from Astragalus species on in vitro cytokine release. J Ethnopharmacol 96 January (1-2) (2005) 71-77
31. Yang Z.G., Sun H.X., and Fang W.H. Haemolytic activities and adjuvant effect of Astragalus membranaceus saponins (AMS) on the immune responses to ovalbumin in mice. Vaccine 23 October (44) (2005) 5196-5203
32. Yoshida Y., Wang M.Q., Liu J.N., Shan B.E., and Yamashita U. Immunomodulating activity of Chinese medicinal herbs and Oldenlandia diffusa in particular. Int J Immunopharmacol 19 July (7) (1997) 359-370
33. Bedir E., Pugh N., Calis I., Pasco D.S., and Khan I.A. Immunostimulatory effects of cycloartane-type triterpene glycosides from astragalus species. Biol Pharm Bull 23 July (7) (2000) 834-837
34. Xu Q.F., Fang X.L., and Chen D.F. Pharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats. J Ethnopharmacol 84 February (2-3) (2003) 187-192
35. 2+, CaM in craniocerebral injury. Zhongguo Zhong Xi Yi Jie He Za Zhi 19 April (4) (1999) 227-229
36. Sun H.X., Ye Y.P., Pan H.J., and Pan Y.J. Adjuvant effect of Panax notoginseng saponins on the immune responses to ovalbumin in mice. Vaccine 22 September (29-30) (2004) 3882-3889
37. Sun H., Ye Y., and Pan H.J. Immunological-Adjuvant Saponins from the Roots of Panax notoginseng. Chem Biodivers 2 April (4) (2005) 510-515
38. Sun H., Yang Z., Ye Y., and Structure. biological activity of protopanaxatriol-type saponins from the roots of Panax notoginseng. Int Immunopharmacol 6 January (1) (2006) 14-25
39. Sun H.X., Qin F., and Ye Y.P. Relationship between haemolytic and adjuvant activity and structure of protopanaxadiol-type saponins from the roots of Panax notoginseng. Vaccine 23 December (48-49) (2005) 5533-5542
40. Iwamoto M., Okabe H., and Yamauchi T. Studies on the constituents of Momordica cochinchinensis SPRENG. II: Isolation and characterization of the root saponins, momordins I, II and III. Chem Pharm Bull 33 1 (1985) 1-7
41. Xiao C.W., Hu S., and Rajput Z.I. Adjuvant effect of an extract from Cochinchina momordica seeds on the immune responses to ovalbumin in mice. Front Agric China 1 1 (2007) 90-95
42. Xiao C., Rajput Z.I., Liu D., and Hu S. Enhancement of serological immune responses to foot-and-mouth disease vaccine by a supplement made of extract of Cochinchina momordica seeds. Clin vaccine Immunol: CVI 14 12 (2007) 1634-1639
43. Sun H.X., and Pan H.J. Immunological adjuvant effect of Glycyrrhiza uralensis saponins on the immune responses to ovalbumin in mice. Vaccine 24 March (11) (2006) 1914-1920
44. Sun H.X. Adjuvant effect of Achyranthes bidentata saponins on specific antibody and cellular response to ovalbumin in mice. Vaccine 24 April (17) (2006) 3432-3439
45. Xie Y., Pan H., Sun H., and Li D. A promising balanced Th1 and Th2 directing immunological adjuvant, saponins from the root of Platycodon grandiflorum. Vaccine 26 July (31) (2008) 3937-3945
46. Committee CPCE. In: Committee CPCE (Ed). Ren Shen (Radix ET Rhizoma Ginseng). The Chinese Pharmaceutical Codex ed. (2005), Chemical Industry Press, Beijing 7-8
47. Liu C.X., and Xiao P.G. Recent advances on ginseng research in China. J Ethnopharmacol 36 February (1) (1992) 27-38
48. Owen R.T. Ginseng: a pharmacological profile. Drugs Today 8 (1981) 343-351
49. Scaglione F., Cattaneo G., Alessandria M., and Cogo R. Efficacy and safety of the standardised Ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold [corrected]. Drugs Exp Clin Res 22 2 (1996) 65-72
50. Scaglione F., Ferrara F., Dugnani S., Falchi M., Santoro G., and Fraschini F. Immunomodulatory effects of two extracts of Panax ginseng C.A. Meyer. Drugs Exp Clin Res 16 10 (1990) 537-542
51. Kim J.Y., Germolec D.R., and Luster M.I. Panax ginseng as a potential immunomodulator: studies in mice. Immunopharmacol Immunotoxicol 12 2 (1990) 257-276
52. Larsen M.W., Moser C., Hoiby N., Song Z., and Kharazmi A. Ginseng modulates the immune response by induction of interleukin-12 production. APMIS 112 June (6) (2004) 369-373
53. Yun Y.S., Moon H.S., Oh Y.R., Jo S.K., Kim Y.J., and Yun T.K. Effect of red ginseng on natural killer cell activity in mice with lung adenoma induced by urethan and benzo(a)pyrene. Cancer Detect Prev Suppl 1 (1987) 301-309
54. Singh V.K., George C.X., Singh N., Agarwal S.S., and Gupta B.M. Combined treatment of mice with Panax ginseng extract and interferon inducer. Amplification of host resistance to Semliki forest virus. Planta Med 47 April (4) (1983) 234-236
55. Lin C.C., Kim H.K., and Parker D. Sensitive high-performance liquid chromatographic method for the determination of a benzonaphthazepine antipsychotic agent, SCH, 39166 and its active metabolite SCH, 40853, in human plasma and its cross-validation with a gas chromatographic method. J Chromatogr B Biomed Appl 682 July (2) (1996) 309-313
56. Committee CPCE. In: Committee CPCE (Ed). Huang Qi (Radix Astragali). The Chinese Pharmaceutical Codex ed., Part I (2005), Chemical Industry Press, Beijing 212-213
57. Rios J.L., and Waterman P.G. A review of the pharmacology and toxicology of Astragalus. Phytother Res 11 (1997) 411-418
58. + channels of mouse T lymphocytes. JN Bethune Univ Med Sci 2 (1996) 125-126
59. Verotta L., Guerrini M., El-Sebakhy N.A., Asaad A.M., Toaima S.M., Abou-Sheer M.E., et al. Cycloartane saponins from Astragalus peregrinus as modulators of lymphocyte proliferation. Fitoterapia 72 December (8) (2001) 894-905
60. Ma W.G., Mizutani M., Malterud K.E., Lu S.L., and Satoshi Tahara S. Saponins from the roots of Panax notoginseng. Phytochemistry 52 November (6) (1999) 1133-1139
61. Du Q., Jerz G., Waibel R., and Winterhalter P. Isolation of dammarane saponins from Panax notoginseng by high-speed counter-current chromatography. J Chromatogr A 1008 August (2) (2003) 173-180
62. Lau A.J., Woo S.O., and Koh H.L. Analysis of saponins in raw and steamed Panax notoginseng using high-performance liquid chromatography with diode array detection. J Chromatogr A 1011 September (1-2) (2003) 77-87
63. Xu G.J. Mu Bie Zi (Semen momordicae). In: Xu Q.F. (Ed). Coloured illustrations of Chinese traditional and herbal drugs. 2nd ed. (1996), Fujian Science & Technology Press, Fuzhou 496
64. Gao X.M. Mu Bie Zi (Semen momordicae). In: Gao X.M. (Ed). Chinese materia medicia (2005), Traditional Chinese Materia Medica Press, Beijing 601-602
65. Oda K., Matsuda H., Murakami T., Katayama S., Ohgitani T., and Yoshikawa M. Relationship between adjuvant activity and amphipathic structure of soyasaponins. Vaccine 21 May (17-18) (2003) 2145-2151
66. Oda K., Matsuda H., Murakami T., Katayama S., Ohgitani T., and Yoshikawa M. Adjuvant and haemolytic activities of 47 saponins derived from medicinal and food plants. Biol Chem 381 January (1) (2000) 67-74
67. Bomford R., Stapleton M., Winsor S., Beesley J.E., Jessup E.A., Price K.R., et al. Adjuvanticity and ISCOM formation by structurally diverse saponins. Vaccine 10 9 (1992) 572-577
68. Katayama S., Oda K., Ohgitani T., Hirahara T., and Shimizu Y. Influence of antigenic forms and adjuvants on the IgG subclass antibody response to Aujeszky's disease virus in mice. Vaccine 17 June (20-21) (1999) 2733-2739
69. Komatsu H., Murakami T., Matsuda H., and Yoshikawa M. Medicinal foodstuffs. XIII. Saponin constituents with adjuvant activity from hyacinth bean, the seeds of Dolichos lablab L. (2): structures of lablabosides D, E, and F. Heterocycles 48 4 (1998) 703-710
70. Nagai T., Suzuki Y., Kiyohara H., Susa E., Kato T., Nagamine T., et al. Onjisaponins, from the root of Polygala tenuifolia Willdenow, as effective adjuvants for nasal influenza and diphtheria-pertussis-tetanus vaccines. Vaccine 19 September (32) (2001) 4824-4834
71. Liu G., Anderson C., Scaltreto H., Barbon J., and Kensil C.R. QS-21 structure/function studies: effect of acylation on adjuvant activity. Vaccine 20 June (21-22) (2002) 2808-2815
72. Rhodes J. Discovery of immunopotentiatory drugs: current and future strategies. Clin Exp Immunol 130 December (3) (2002) 363-369
73. Oliveira-Freitas E., Casas C.P., Borja-Cabrera G.P., Santos F.N., Nico D., Souza L.O., et al. Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis. Vaccine 24 May (18) (2006) 3909-3920
74. Marciani D.J., Reynolds R.C., Pathak A.K., Finley-Woodman K., and May R.D. Fractionation, structural studies, and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100. Vaccine 21 September (25-26) (2003) 3961-3971
75. Tsoi A.Y., Ng T.B., and Fong W.P. Antioxidative effect of a chymotrypsin inhibitor from Momordica cochinchinensis (Cucurbitaceae) seeds in a primary rat hepatocyte culture. J Pept Sci 11 October (10) (2005) 665-668
76. Glaueri A.M., Dingle J.T., and Lucy J.A. Action of saponins on biological membranes. Nature 196 (1962) 953
77. Sjolander A., Drane D., Maraskovsky E., Scheerlinck J.P., Suhrbier A., Tennent J., et al. Immune responses to ISCOM formulations in animal and primate models. Vaccine 19 March (17-19) (2001) 2661-2665
78. Nakaya T.A., Kita M., Kuriyama H., Iwakura Y., and Imanishi J. Panax ginseng induces production of proinflammatory cytokines via toll-like receptor. J Interf Cytok Res 24 February (2) (2004) 93-100
79. Kersten G.F., and Crommelin D.J. Liposomes and ISCOMs. Vaccine 21 February (9-10) (2003) 915-920
80. Pearse M.J., and Drane D. ISCOMATRIX adjuvant for antigen delivery. Adv Drug Deliv Rev 57 January (3) (2005) 465-474
81. Sanders M.T., Brown L.E., Deliyannis G., and Pearse M.J. ISCOM-based vaccines: the second decade. Immunol Cell Biol 83 April (2) (2005) 119-128
82. Myschik J., Lendemans D.G., McBurney W.T., Demana P.H., Hook S., and Rades T. On the preparation, microscopic investigation and application of ISCOMs. Micron 37 8 (2006) 724-734